Kim CJ - Search Results

1

Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer.

Kim NW, Chu CW, Ahn TS, Kim CJ, Jung DJ, Son MW, Bae SH, Lee MS, Kim CH, Baek MJ. Kim NW, et al. Among authors: kim ch, kim cj. J Korean Soc Coloproctol. 2011 Oct;27(5):231-6. doi: 10.3393/jksc.2011.27.5.231. Epub 2011 Oct 31. J Korean Soc Coloproctol. 2011. PMID: 22102972 Free PMC article.

2

Characterization of aberrant FHIT transcripts in gastric adenocarcinomas.

Lee SH, Kim CJ, Park HK, Koh JW, Cho MH, Baek MJ, Lee MS. Lee SH, et al. Among authors: kim cj. Exp Mol Med. 2001 Sep 30;33(3):124-30. doi: 10.1038/emm.2001.22. Exp Mol Med. 2001. PMID: 11642547

3

MRI of gastric carcinoma: results of T and N-staging in an in vitro study.

Kim IY, Kim SW, Shin HC, Lee MS, Jeong DJ, Kim CJ, Kim YT. Kim IY, et al. Among authors: kim sw, kim cj, kim yt. World J Gastroenterol. 2009 Aug 28;15(32):3992-8. doi: 10.3748/wjg.15.3992. World J Gastroenterol. 2009. PMID: 19705493 Free PMC article.

4

Expression of the survivin-2B splice variant related to the progression of colorectal carcinoma.

Cho GS, Ahn TS, Jeong D, Kim JJ, Kim CJ, Cho HD, Park DK, Baek MJ. Cho GS, et al. Among authors: kim jj, kim cj. J Korean Surg Soc. 2011 Jun;80(6):404-11. doi: 10.4174/jkss.2011.80.6.404. Epub 2011 Jun 9. J Korean Surg Soc. 2011. PMID: 22066067 Free PMC article.

5

Stromal-cell-derived Factor 1-α Promotes Tumor Progression in Colorectal Cancer.

Park SJ, Ahn TS, Cho SW, Kim CJ, Jung DJ, Son MW, Bae SH, Shin EJ, Lee MS, Kim CH, Baek MJ. Park SJ, et al. Among authors: kim ch, kim cj. J Korean Soc Coloproctol. 2012 Feb;28(1):27-34. doi: 10.3393/jksc.2012.28.1.27. Epub 2012 Feb 29. J Korean Soc Coloproctol. 2012. PMID: 22413079 Free PMC article.

6

RhoA is associated with invasion and poor prognosis in colorectal cancer.

Jeong D, Park S, Kim H, Kim CJ, Ahn TS, Bae SB, Kim HJ, Kim TH, Im J, Lee MS, Kwon HY, Baek MJ. Jeong D, et al. Among authors: kim h, kim hj, kim th, kim cj. Int J Oncol. 2016 Feb;48(2):714-22. doi: 10.3892/ijo.2015.3281. Epub 2015 Dec 8. Int J Oncol. 2016. PMID: 26648547

7

Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma.

Kim H, Ahn TS, Kim CJ, Bae SB, Kim HJ, Lee CS, Kim TH, Im J, Lee SH, Son MW, Lee MS, Baek MJ, Jeong D. Kim H, et al. Among authors: kim hj, kim th, kim cj. Oncol Lett. 2017 Jul;14(1):553-560. doi: 10.3892/ol.2017.6203. Epub 2017 May 18. Oncol Lett. 2017. PMID: 28693205 Free PMC article.

8

Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.

Jeong D, Kim H, Ban S, Oh S, Ji S, Kim D, Ahn TS, Kim HJ, Bae SB, Kwon HY, Im J, Lee MS, Cho HD, Kim CJ, Baek MJ. Jeong D, et al. Among authors: kim h, kim hj, kim d, kim cj. J Cancer Res Clin Oncol. 2017 Dec;143(12):2493-2503. doi: 10.1007/s00432-017-2512-5. Epub 2017 Sep 5. J Cancer Res Clin Oncol. 2017. PMID: 28875407

9

Protein kinase, membrane‑associated tyrosine/threonine 1 is associated with the progression of colorectal cancer.

Jeong D, Kim H, Kim D, Ban S, Oh S, Ji S, Kang D, Lee H, Ahn TS, Kim HJ, Bae SB, Lee MS, Kim CJ, Kwon HY, Baek MJ. Jeong D, et al. Among authors: kim h, kim hj, kim d, kim cj. Oncol Rep. 2018 Jun;39(6):2829-2836. doi: 10.3892/or.2018.6371. Epub 2018 Apr 13. Oncol Rep. 2018. PMID: 29658598

10

Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancer.

Jeong D, Kim H, Kim D, Ban S, Oh S, Ji S, Kang D, Lee H, Ahn TS, Kim HJ, Bae SB, Lee MS, Kim CJ, Kwon HY, Baek MJ. Jeong D, et al. Among authors: kim h, kim hj, kim d, kim cj. Cancer Biomark. 2019;24(4):485-495. doi: 10.3233/CBM-182221. Cancer Biomark. 2019. PMID: 30932884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,429 results

Search Page